SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs plan to acquire low-band spectrum and expand Starlink Mobile into a wireless carrier has raised concerns about future competition, weighing on T-Mobile shares. Traders debate whether the selloff reflects a genuine long-term threat or an overreaction given SpaceXs need to build out its network and T-Mobiles existing customer base and infrastructure.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

The FDAs acceptance of Intellias lonvo-z application for priority review, with a March 2027 decision date, is driving discussion as traders focus on a potential first-in-class gene-editing treatment for hereditary angioedema. Bulls view the milestone as progress toward commercialization, while skeptics point to weak price action, financing and adoption risks, and heavy short interest.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRXs rally and heavy-volume trading are drawing attention ahead of founder Patrick Soon-Shiongs scheduled Oct. 16 fireside chat, where traders expect updates on clinical trials and the companys immunotherapy pipeline. Bulls point to potential trial or partnership news and short-covering, but the partnership rumors remain unconfirmed and some investors are cautious about the lack of concrete new results.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

A sharp post-earnings rally followed by a volatile pullback is driving discussion, with traders debating whether the decline is low-volume/options-related consolidation or a sign of renewed weakness. Bulls point to improving growth and cash flow, while bears focus on the stock giving back earnings gains and lingering concerns about dilution and debt.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoins rally is drawing attention after Arthur Hayes publicly backed the token with a bullish price call; traders are debating the significance of that endorsement after reports that he later sold his position, with some accusing him of pumping and dumping WLD. ETF hopes and Worldcoins proof-of-humanity pitch for an AI-driven internet also feature in the broader bullish discussion.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Reported takeover interest from Lundbeck is driving attention, with traders speculating about a possible offer or bidding war despite Xeris saying it is not for sale. The chatter remains unconfirmed, and some investors argue the companys Recorlev growth and XP-8121 pipeline could be worth more if it continues independently.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is drawing attention for perceived resilience versus Bitcoin and speculation that the upcoming Layla/CashVM upgrade could support a breakout. Bulls point to the upgrade and relative strength, while skeptics highlight BCHs weak utility and risk of further declines.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIBs conversation centers on prolonged, range-bound consolidation, with traders watching for a breakout and hoping for a renewed meme-coin rally. Optimists describe accumulation and improving chart patterns, while skeptics point to repeated stagnation and the risk of further declines.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the following business segments: Consumer and Business. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon shares sold off as SpaceXs planned acquisition of low-band spectrum heightened concerns that Starlink Mobile could eventually compete for wireless customers. Traders disagree on the scale and timing of the threat: some see a major challenge to incumbent carriers, while others view the reaction as excessive given the years and infrastructure needed to build a competitive network, and are buying the dip for Verizons dividend.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Reported increases in JasmyChain activity, including JLP transfers and transactions using JASMY for gas, have traders debating whether the ecosystem is beginning to see real use. Bulls view this as an early sign of utility, while skeptics say activity remains limited and point to exchange delistings and weak relative performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These Innovators Are Making Bold Moves—From AI Glasses To Next-Generation Biotech

Emerging growth companies continue to focus on commercialization, manufacturing readiness, artificial intelligence integration and differentiated technologies as they pursue long-term growth opportunities. $ELAB, $KBLB, $GMM, $LUCY

NorthStrive Biosciences Sharpens EL-22 Development as Manufacturing Validation Advances Muscle-Preservation Program

NorthStrive Biosciences, a subsidiary of PMGC Holdings (NASDAQ:ELAB), is taking another step toward advancing its engineered probiotic platform by initiating an independent flow cytometry (FACS) characterization program for EL-22, its lead therapeutic candidate designed to help preserve muscle during weight-loss treatment, including the rapidly expanding use of GLP-1 receptor agonists.

AI, Clinical Data, and Regulatory Catalysts have Wall Street Watching These Biotechs

Three emerging biotechnology companies, Can-Fite BioPharma (NYSEAMERICAN:CANF), NeOnc Technologies (NASDAQ:NTHI), and PMGC Holdings (NASDAQ:ELAB) through its NorthStrive Biosciences subsidiary, are pursuing a distinct therapeutic strategy, the common theme is execution. Clinical data, regulatory milestones, AI-assisted discovery platforms, and expanding development pipelines are creating a steady stream of catalysts that investors will be watching closely during the second half of 2026.

Why Is ELAB Stock Rising Today?

Equity

PMGC Holdings acquired a controlling stake of 76% in an Arizona-based company that serves in aerospace, space, defense, semiconductor, and medical-device markets.

This Small-Cap Firm Is Chasing The Aerospace, Defense Boom With Fresh $40M – But Retail Isn’t Fully Buying It 

PMGC secured an agreement to draw additional funds beyond the $40 million financing for the next 24 months.

What's Going On With PMGC Holdings Stock?

Shares of PMGC Holdings Inc. (NASDAQ: ELAB) are trading higher on Monday after the company announced one of its subsidiaries, NorthStrive Biosciences, transferred a key project to a U.S.-based...

Why PMGC Holdings Stock Is Falling Friday?

PMGC Holdings Inc. (NASDAQ: ELAB) stock drops Friday as traders react to share dilution concerns following a volatile week for the defense tech firm.read more...

These Stocks are Turning Heads

A wave of innovation across AI robotics, biotechnology, advanced materials, and clean energy is reshaping the small-cap landscape. $ONCO, $KBLB, $ELAB, $GLMD, $TURB, $GAME

Why Is PMGC Holdings Stock Gaining Thursday?

AGA Precision expands defense role with new Tier 1 aerospace contract under parent PMGC Holdings (NASDAQ: ELAB).read more...

ELAB Stock Surges 40% After PMGC Discloses Full Utilization Of $20M Funding Facility – Company Says It’s Fully Funded For Near-Term Acquisitions

PMGC had entered into a share sale agreement with Streeterville last September.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$3.08
Prev Close	$3.13
Open	$3.12
Dividend Yield	0.00%
50-Day Moving Average	$5.83
Beta	1.95
Avg. Volume	52,073.90
PE Ratio	0.00

52-Week High	$2,671.20
52-Week Low	$2.59
Market Capitalization	$2.53M
EPS (Annual)	-$3,787.42
Price to Book	0.11
Revenue Per Employee	$17,355.41

Feed

News

Sentiment

Earnings

Fundamentals

Info

ELAB Fundamentals